Thematics Asset Management lessened its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 7.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 142,535 shares of the semiconductor company’s stock after selling 11,785 shares during the quarter. Synopsys makes up approximately 3.2% of Thematics Asset Management’s holdings, making the stock its 3rd biggest holding. Thematics Asset Management owned about 0.08% of Synopsys worth $70,325,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Stanley Laman Group Ltd. boosted its stake in Synopsys by 542.9% during the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock worth $6,353,000 after acquiring an additional 10,874 shares during the last quarter. Symphony Financial Ltd. Co. increased its stake in Synopsys by 4,780.9% in the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock valued at $20,638,000 after purchasing an additional 39,395 shares in the last quarter. Empirical Asset Management LLC bought a new stake in Synopsys in the third quarter valued at approximately $773,000. Strategic Advisors LLC raised its holdings in Synopsys by 76.3% in the third quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company’s stock worth $3,739,000 after purchasing an additional 3,279 shares during the period. Finally, Napean Trading & Investment Co Singapore PTE Ltd raised its holdings in Synopsys by 17.6% in the second quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 23,683 shares of the semiconductor company’s stock worth $12,142,000 after purchasing an additional 3,544 shares during the period. 85.47% of the stock is owned by institutional investors.
Synopsys Trading Down 1.5%
Shares of NASDAQ:SNPS opened at $412.63 on Friday. The firm has a market cap of $79.04 billion, a price-to-earnings ratio of 64.07, a PEG ratio of 3.41 and a beta of 1.15. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company’s fifty day simple moving average is $461.93 and its 200 day simple moving average is $464.57. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on the stock. KeyCorp boosted their price target on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a report on Thursday, December 11th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and reduced their target price for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Citigroup assumed coverage on Synopsys in a research note on Monday, November 24th. They issued a “buy” rating and a $580.00 target price for the company. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the stock a “buy” rating in a report on Wednesday, February 25th. Finally, Piper Sandler cut their price objective on Synopsys from $520.00 to $430.00 and set a “neutral” rating on the stock in a report on Thursday, February 26th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $531.00.
View Our Latest Research Report on SNPS
Insider Transactions at Synopsys
In other news, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares in the company, valued at approximately $8,221,058.34. This represents a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 4,157 shares of company stock worth $1,945,036. Corporate insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Stories
- Five stocks we like better than Synopsys
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Forget oil — this changes everything about American energy…
- $30 stock to buy before Starlink goes public (WATCH NOW!)
- This coin has everything going for it
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
